Reports

Ideas That Generate Results

Brazil Generics Market Forecast to 2012

Brazil Generics Market Forecast to 2012

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jan, 2011| No. of Pages : 60

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1000.00  600.00
CD-ROM Mail Delivery
US$ 1100.00  650.00
Hard Copy Mail Delivery
US$ 1100.00  700.00
Electronic Access - Multi-User License
US$ 1400.00  750.00

List of Figures:

Figure 4-1: Population aged above 65 Years (%), 2006-2010
Figure 4-2: Share of Prescriptions for Branded & Generic Drugs in Pharmaceutical Market (2008 & 2009)
Figure 5-1: Generic Drugs Market (Billion BRL), 2008-2012
Figure 5-2: Share of Generic Drugs in Pharmaceutical Market (2010)
Figure 5-3: Generic Drugs Market (Million Units), 2007-2010
Figure 5-4: Growth of Pharmaceutical & Generics Market (%), 2010-2012
Figure 5-5: Number of HIV Patients & HIV Patients on HAART (‘000), 2009
Figure 5-6: Share of Key Players in Oral Contraceptives Market
Figure 5-7: Share of Key Drugs in Erectile Dysfunction Market (2008)
Figure 5-8: Deaths from Cardiovascular Diseases (%), 2006 & 2030
Figure 5-9: Cardiovascular Drugs Market (Million US$), 2005 & 2006
Figure 5-10: Share of Branded & Generic Drugs in Cardiovascular Drugs Market (2009)
Figure 5-11: Insulin Market (Million BRL), 2007-2009
Figure 6-1: Share of Domestic & Multinational Companies in Generics Market (2010)
Figure 7-1: Government Medicines Expenditure by Type (%), 2007
Figure 8-1: Share of Imported & Locally Produced Raw Material for Pharmaceutical Market (2008)
Figure 9-1: Share of Key Players in Generics Market

List of Tables:

Table 4-1: Patent Expiry of Key Drugs
Table 5-1: Market Share of Top Pharmaceutical Companies
Table 5-2: Erectile Dysfunction Market Overview (2007 & 2008)
Table 5-3: Diabetic Patients in Age Group 20-79 Years ('000), 2010
Table 5-4: Forecast for Diabetic Patients in Age Group 20-79 Years ('000), 2030
Table 9-1: EMS Sigma Pharma - Strengths & Weaknesses
Table 9-2: Medley - Strengths & Weaknesses
Table 9-3: Eurofarma Laboratories Ltd - Strengths & Weaknesses
Table 9-4: Aché Pharmaceutical Laboratories S/A - Strengths & Weaknesses
Table 9-5: Ranbaxy - Strengths & Weaknesses

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.